Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
Shauna M. Collins(The Ohio State University), Courtney E. Bakan(The Ohio State University), Gina D. Swartzel(The Ohio State University), Craig C. Hofmeister(The Ohio State University), Yvonne A. Efebera(The Ohio State University), Hakju Kwon(AbbVie (United States)), Gary C. Starling(Merck & Co., Inc., Rahway, NJ, USA (United States)), David Ciarlariello(The Ohio State University), Shakthi Bhaskar(The Ohio State University), Edward L. Briercheck(The Ohio State University), Tiffany Hughes(The Ohio State University), Jianhua Yu(The Ohio State University), Audie Rice(AbbVie (United States)), Don M. Benson(The Ohio State University)
Cited by 293
Abstract
Related Papers
No related papers found
Powered by citation graph analysis